Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Topogenesis and homeostasis of fatty acyl-CoA reductase 1.

Honsho M, Asaoku S, Fukumoto K, Fujiki Y.

J Biol Chem. 2013 Nov 29;288(48):34588-98. doi: 10.1074/jbc.M113.498345. Epub 2013 Oct 9.

2.

The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.

Sato H, Hagiwara H, Senba H, Fukumoto K, Nagashima Y, Yamasaki H, Ueno K, Yano T.

Mol Carcinog. 2008 Jun;47(6):403-9.

PMID:
18058801
3.

Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.

Sato H, Fukumoto K, Hada S, Hagiwara H, Fujimoto E, Negishi E, Ueno K, Yano T.

Cancer Chemother Pharmacol. 2007 Aug;60(3):449-57. Epub 2007 Feb 16.

PMID:
17569045
4.

Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.

Sato H, Senba H, Virgona N, Fukumoto K, Ishida T, Hagiwara H, Negishi E, Ueno K, Yamasaki H, Yano T.

Mol Carcinog. 2007 Mar;46(3):215-24.

PMID:
17186540
5.

Expression patterns of connexin 26 and connexin 43 mRNA in canine benign and malignant mammary tumours.

Gotoh H, Harada K, Suzuki K, Hashimoto S, Yamamura H, Sato T, Fukumoto K, Hagiwara H, Ishida T, Yamada K, Asano R, Yano T.

Vet J. 2006 Jul;172(1):178-80.

PMID:
16772144
6.

Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.

Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.

Life Sci. 2006 Apr 4;78(19):2249-54. Epub 2005 Nov 11.

PMID:
16289236
7.

Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth.

Fukumoto K, Yano Y, Virgona N, Hagiwara H, Sato H, Senba H, Suzuki K, Asano R, Yamada K, Yano T.

FEBS Lett. 2005 Jul 4;579(17):3829-36.

8.

Prevention of renal cell carcinoma from hemodialysis patients by regulating epigenetic factors.

Sumiko S, Hiromi H, Hiromi S, Keiko F, Shigeto K, Taiichiro S, Toyohiko A, Kiyokazu H, Hiroshi Y, Tomohiro Y.

Kidney Int. 2005 Jun;67(6):2506-7. No abstract available.

9.

Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cells.

Yonezawa Y, Nagashima Y, Sato H, Virgona N, Fukumoto K, Shirai S, Hagiwara H, Seki T, Ariga T, Senba H, Suzuki K, Asano R, Hagiwara K, Yano T.

Mol Carcinog. 2005 Aug;43(4):188-97.

PMID:
15864803
10.

A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.

Fujimoto E, Sato H, Nagashima Y, Negishi E, Shirai S, Fukumoto K, Hagiwara H, Hagiwara K, Ueno K, Yano T.

Life Sci. 2005 Apr 22;76(23):2711-20. Epub 2005 Jan 28.

PMID:
15792837
11.

Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.

Fujimoto E, Sato H, Shirai S, Nagashima Y, Fukumoto K, Hagiwara H, Negishi E, Ueno K, Omori Y, Yamasaki H, Hagiwara K, Yano T.

Oncogene. 2005 May 19;24(22):3684-90.

PMID:
15782139
12.

Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox-silent derivative of alpha-tocotrienol.

Yano Y, Satoh H, Fukumoto K, Kumadaki I, Ichikawa T, Yamada K, Hagiwara K, Yano T.

Int J Cancer. 2005 Jul 10;115(5):839-46.

13.

Cytotoxic effect of the Her-2/Her-1 inhibitor PKI-166 on renal cancer cells expressing the connexin 32 gene.

Fujimoto E, Yano T, Sato H, Hagiwara K, Yamasaki H, Shirai S, Fukumoto K, Hagiwara H, Negishi E, Ueno K.

J Pharmacol Sci. 2005 Feb;97(2):294-8. Epub 2005 Feb 5.

Supplemental Content

Loading ...
Support Center